Smith Salley Wealth Management’s Gilead Sciences GILD Stock Holding History

Smith Salley Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,480	Closed	-$206K	–	281
2026 Q1	$206K	Buy	+1,480	New	+$207K	0.01%	264
2024 Q1	–	Sell	-10,099	Closed	-$818K	–	232
2023 Q4	$818K	Sell	10,099 -57	-0.6%	-$4.44K	0.05%	152
2023 Q3	$761K	Sell	10,156 -826	-8%	-$63.5K	0.06%	145
2023 Q2	$846K	Sell	10,982 -1,188	-10%	-$94.7K	0.06%	137
2023 Q1	$1.01M	Sell	12,170 -552	-4%	-$45.7K	0.08%	126
2022 Q4	$1.09M	Buy	12,722 +97	+0.8%	+$7.68K	0.09%	126
2022 Q3	$779K	Hold	12,625	–	–	0.07%	135
2022 Q2	$780K	Buy	12,625 +857	+7%	+$53.1K	0.07%	143
2022 Q1	$700K	Sell	11,768 -46,544	-80%	-$2.98M	0.05%	162
2021 Q4	$4.23M	Sell	58,312 -82	-0.1%	-$5.65K	0.3%	74
2021 Q3	$4.08M	Sell	58,394 -191	-0.3%	-$13.4K	0.32%	70
2021 Q2	$4.03M	Buy	58,585 +1,343	+2%	+$89.7K	0.33%	67
2021 Q1	$3.7M	Buy	57,242 +11,777	+26%	+$759K	0.33%	68
2020 Q4	$2.65M	Sell	45,465 -3,207	-7%	-$194K	0.27%	76
2020 Q3	$3.08M	Sell	48,672 -3,184	-6%	-$221K	0.37%	67
2020 Q2	$3.99M	Sell	51,856 -6,232	-11%	-$478K	0.53%	55
2020 Q1	$4.34M	Buy	58,088 +11,441	+25%	+$791K	0.72%	45
2019 Q4	$3.03M	Sell	46,647 -2,780	-6%	-$181K	0.4%	71
2019 Q3	$3.13M	Buy	49,427 +836	+2%	+$54.6K	0.45%	65
2019 Q2	$3.28M	Sell	48,591 -1,075	-2%	-$70.7K	0.49%	61
2019 Q1	$3.23M	Buy	49,666 +4,136	+9%	+$275K	0.52%	62
2018 Q4	$2.85M	Sell	45,530 -4,200	-8%	-$294K	0.52%	64
2018 Q3	$3.84M	Sell	49,730 -1,733	-3%	-$131K	0.61%	59
2018 Q2	$3.65M	Sell	51,463 -415	-0.8%	-$29.3K	0.62%	55
2018 Q1	$3.91M	Sell	51,878 -257	-0.5%	-$20.4K	0.7%	56
2017 Q4	$3.73M	Buy	52,135 +30	+0.1%	+$2.28K	0.67%	60
2017 Q3	$4.22M	Buy	52,105 +27,824	+115%	+$2.13M	0.81%	47
2017 Q2	$1.72M	Sell	24,281 -33	-0.1%	-$2.2K	0.35%	85
2017 Q1	$1.65M	Sell	24,314 -903	-4%	-$63.5K	0.34%	85
2016 Q4	$1.81M	Sell	25,217 -1,657	-6%	-$123K	0.38%	82
2016 Q3	$2.13M	Sell	26,874 -1,440	-5%	-$117K	0.47%	71
2016 Q2	$2.36M	Sell	28,314 -2,400	-8%	-$213K	0.55%	64
2016 Q1	$2.82M	Sell	30,714 -1,638	-5%	-$148K	0.71%	48
2015 Q4	$3.27M	Sell	32,352 -1,157	-3%	-$120K	0.82%	42
2015 Q3	$3.29M	Sell	33,509 -823	-2%	-$91.4K	0.89%	39
2015 Q2	$4.02M	Sell	34,332 -2,397	-7%	-$262K	1.02%	37
2015 Q1	$3.6M	Sell	36,729 -4,956	-12%	-$503K	0.92%	42
2014 Q4	$3.93M	Sell	41,685 -3,728	-8%	-$386K	1.02%	36
2014 Q3	$4.83M	Sell	45,413 -4,497	-9%	-$440K	1.28%	22
2014 Q2	$4.14M	Buy	+49,910	New	+$3.88M	1.1%	26

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Smith Salley Wealth Management's GILD Position: Q2 2026 in Review

Smith Salley Wealth Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,480 shares — an estimated $206K sold.

Smith Salley Wealth Management first reported a position in GILD in Q2 2014 and held it in 40 quarters. The position peaked at $4.83M in Q3 2014. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Smith Salley Wealth Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Smith Salley Wealth Management sold 1,480 Gilead Sciences shares in Q2 2026, an estimated $206K.
Smith Salley Wealth Management first reported a position in Gilead Sciences in Q2 2014 and held it in 40 quarters.
Smith Salley Wealth Management's Gilead Sciences position peaked at $4.83M in Q3 2014.
1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Smith Salley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.